Literature DB >> 16769336

Surgical management of lipoblastoma.

Marcene R McVay1, Jennifer E Keller, Charles W Wagner, Richard J Jackson, Samuel D Smith.   

Abstract

BACKGROUND/
PURPOSE: Lipoblastoma/lipoblastomatosis, a rare benign pediatric tumor composed of embryonic fat, most often presents as a rapidly growing mass in children younger than 3 years. This benign tumor locally recurs up to 25% of the time. This retrospective review was done to emphasize problems with diagnosis, management, and the approach to follow-up care.
METHODS: Sixteen cases of pathologically proven lipoblastoma presenting to a single institution over a 16-year period (1988-2004) were reviewed retrospectively for clinical features and outcome.
RESULTS: There were 11 males and 5 females ranging in age from 18 days to 12.75 years. Preoperative diagnoses were accurate in only 3 cases. Two lesions recurred locally over a period of 10 months and 5 years. One lesion presented with local infiltration. Six lesions were right-sided, 5 were left-sided, and 5 were midline.
CONCLUSIONS: It is important to consider lipoblastoma in the diagnosis of a rapidly enlarging fatty mass in children. Complete resection is the only definitive treatment and should not be delayed when impingement on surrounding structures is imminent. There is a tendency for these lesions to recur despite presumed complete excision. Therefore, follow-up for a minimum of 5 years is recommended.

Entities:  

Mesh:

Year:  2006        PMID: 16769336     DOI: 10.1016/j.jpedsurg.2006.02.025

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  19 in total

1.  Unusual breast enlargement in an infant: a case of breast lipoblastoma.

Authors:  Augusto Zani; Denis A Cozzi; Stefania Uccini; Francesco Cozzi
Journal:  Pediatr Surg Int       Date:  2006-10-19       Impact factor: 1.827

2.  Primary paediatric chest wall tumours necessitating surgical management.

Authors:  N Maistry; J Durell; S Wilson; K Lakhoo
Journal:  Ann R Coll Surg Engl       Date:  2020-03-11       Impact factor: 1.891

3.  Follow-up outcomes of pediatric patients who underwent surgical resection for lipoblastomas or lipoblastomatosis: a single-institution experience with a systematic review and meta-analysis.

Authors:  Dyda Dao; Anna J Najor; Philip Y Sun; Forough Farrokhyar; Christopher R Moir; Michael B Ishitani
Journal:  Pediatr Surg Int       Date:  2020-01-14       Impact factor: 1.827

4.  Giant abdomino-pelvic adipose tumors of childhood.

Authors:  Valentina Cascini; Gabriele Lisi; Giuseppe Lauriti; Giulia Sindici; Pierluigi Lelli Chiesa
Journal:  Pediatr Surg Int       Date:  2011-08-30       Impact factor: 1.827

Review 5.  The role of the plain radiograph in the characterisation of soft tissue tumours.

Authors:  Louise Gartner; Christopher J Pearce; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2008-06-20       Impact factor: 2.199

6.  A Massive Intratumoral Aneurysmal Vessel in a Retroperitoneal Lipoblastoma.

Authors:  Suk-Bae Moon
Journal:  Indian J Surg       Date:  2013-08-02       Impact factor: 0.656

Review 7.  Perineal lipoblastoma: a case report and review of literature.

Authors:  Qiang Liu; Zheng Xu; Shunbao Mao; Rongyao Zeng; Wenyou Chen; Qiang Lu; Yihe Guo; Jing Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

8.  Lipoblastomas presenting in older children and adults: analysis of 22 cases with identification of novel PLAG1 fusion partners.

Authors:  Karen Fritchie; Lu Wang; Zhaohong Yin; Joy Nakitandwe; Dale Hedges; Andrew Horvai; Jorge Torres Mora; Andrew L Folpe; Armita Bahrami
Journal:  Mod Pathol       Date:  2020-10-23       Impact factor: 7.842

9.  Mediastinal lipoblastoma: unexpected finding of a chest infection.

Authors:  Mohammad Hanafiah; Mohammad Noryati; Talib Arni
Journal:  BMJ Case Rep       Date:  2013-06-03

10.  Current management of lipoblastoma.

Authors:  Emmanuelle Séguier-Lipszyc; Artur Baazov; Suzanna Fichman; Shifra Ash; Enrique Freud
Journal:  Eur J Pediatr       Date:  2017-12-14       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.